GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunny Pharmtech Inc (ROCO:6676) » Definitions » Research & Development

Sunny Pharmtech (ROCO:6676) Research & Development : NT$219.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sunny Pharmtech Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sunny Pharmtech's Research & Development for the six months ended in Dec. 2024 was NT$133.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was NT$219.3 Mil.

Sunny Pharmtech Research & Development Historical Data

The historical data trend for Sunny Pharmtech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunny Pharmtech Research & Development Chart

Sunny Pharmtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 182.04 171.37 255.88 208.87 219.28

Sunny Pharmtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 140.09 99.49 109.37 86.03 133.26

Sunny Pharmtech Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$219.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunny Pharmtech  (ROCO:6676) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sunny Pharmtech Research & Development Related Terms

Thank you for viewing the detailed overview of Sunny Pharmtech's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunny Pharmtech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunny Pharmtech Inc (ROCO:6676) » Definitions » Research & Development
Comparable Companies
ROCO:4130 ROCO:6748 TPE:1762 ROCO:1295 ROCO:6461 ROCO:6704 ROCO:7754 ROCO:6892 ROCO:6846 ROCO:6580 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.255,Longyuan 1st Road, Hsinchu Science Park, Longtan District, Taoyuan, TWN, 325002
Website
http://www.sunnypharmtech.com
Sunny Pharmtech Inc is a specialty pharmaceutical company. It is now fully-integrated, doing research, development, and manufacturing on both API and finished-dose products, which includes orals, liquids, semi-solids, and parenterals.

Sunny Pharmtech Headlines

No Headlines